European Medical Solutions (LTS:0RGO) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 12, 2026)


LTS:0RGO European Medical Solutions LTS:0RGO
43 GF Score
Price €4.70
GF Value €9.64
! 2 Warning Signs
View Full Analysis

What is European Medical Solutions Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

European Medical Solutions's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

LTS:0RGO vs VRTX, REGN, ALNY: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, European Medical Solutions's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

European Medical Solutions Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, European Medical Solutions's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where European Medical Solutions's Margin of Safety % (DCF Earnings Based) falls into.


LTS:0RGO
43GF Score
European Medical Solutions LTS:0RGO
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is European Medical Solutions (LTS:0RGO) Overvalued in 2026?

Based on GuruFocus' analysis, European Medical Solutions stock appears to be undervalued. The current stock price of €4.70 is trading 51.2% below its estimated GF Value™ of €9.64.

Key valuation signals for LTS:0RGO:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: €9.64 vs. price of €4.70 (51.2% below fair value)
  • GF Score™: 43/100 with 2 warning signs

No single metric tells the full story. See the LTS:0RGO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

European Medical Solutions Business Description

Other Exchanges ALEMS:Belgium
Address 7 Rue des Chasseurs Ardennais, Liege, BEL, 4031
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.
43GF Score

Get the complete analysis for LTS:0RGO

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.70
Price
€9.64
GF Value